Caroline MD - Lonza Chief Officer
| LZAGF Stock | USD 606.75 17.50 2.97% |
Insider
Caroline MD is Chief Officer of Lonza Group
| Age | 51 |
| Phone | 41 61 316 81 11 |
| Web | https://www.lonza.com |
Lonza Management Efficiency
The company has return on total asset (ROA) of 0.057 % which means that it generated a profit of $0.057 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1189 %, meaning that it generated $0.1189 on every $100 dollars invested by stockholders. Lonza's management efficiency ratios could be used to measure how well Lonza manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Ruby Chandy | Thermo Fisher Scientific | 58 | |
| Stephen Fairy | Sonic Healthcare Ltd | N/A | |
| Alexander MD | Illumina | 47 | |
| Stephanie Campos | Illumina | N/A | |
| Mrs Schottdorf | Sonic Healthcare Ltd | N/A | |
| Dan Welch | Waters | 58 | |
| FAICD FRCPA | Sonic Healthcare Ltd | 68 | |
| Thomas Theuringer | Qiagen NV | N/A | |
| Otis Brawley | Agilent Technologies | 61 | |
| Prashan Kulasekera | Sonic Healthcare Ltd | 51 | |
| Belinda Hyde | Waters | 53 | |
| Gianluca Pettiti | Thermo Fisher Scientific | 45 | |
| Kevin Pegels | Illumina | 56 | |
| Scott Ericksen | Illumina | 51 | |
| BCom FACID | Sonic Healthcare Ltd | 64 | |
| Victoria Creamer | Charles River Laboratories | 54 | |
| Syed Jafry | Thermo Fisher Scientific | 56 | |
| BEc CA | Sonic Healthcare Ltd | 56 | |
| Susan Tousi | Illumina | 55 | |
| Flavia Pease | Charles River Laboratories | 51 | |
| Julian Adler | Sonic Healthcare Ltd | N/A | |
Management Performance
| Return On Equity | 0.12 | |||
| Return On Asset | 0.057 |
Lonza Group Leadership Team
Elected by the shareholders, the Lonza's board of directors comprises two types of representatives: Lonza inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Lonza. The board's role is to monitor Lonza's management team and ensure that shareholders' interests are well served. Lonza's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Lonza's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Philippe Deecke, Chief Officer | ||
| Victoria Morgan, Head Communications | ||
| PierreAlain Ruffieux, Chief Officer | ||
| Andreas Bohrer, Group Sec | ||
| Jennifer Clancy, Director Marketing | ||
| Dirk Oehlers, VP Relations | ||
| Constance Ward, Head Communications | ||
| Caroline MD, Chief Officer | ||
| Maria Nunez, Head Operations | ||
| Sanna Fowler, Head Communications |
Lonza Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Lonza a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.12 | |||
| Return On Asset | 0.057 | |||
| Profit Margin | 0.20 % | |||
| Operating Margin | 0.25 % | |||
| Current Valuation | 36.21 B | |||
| Shares Outstanding | 74.19 M | |||
| Shares Owned By Insiders | 0.07 % | |||
| Shares Owned By Institutions | 52.90 % | |||
| Price To Earning | 41.63 X | |||
| Price To Book | 3.37 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Lonza Pink Sheet
Lonza financial ratios help investors to determine whether Lonza Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lonza with respect to the benefits of owning Lonza security.